CTL IP Series 2: What is Patent Eligible in the U.S.?
3/19/2021 from 12 pm to 1 pm (EST) For this second virtual meeting of the IP series, Dr. John D. Lop...
3/19/2021 from 12 pm to 1 pm (EST) For this second virtual meeting of the IP series, Dr. John D. Lop...
Jess Stein, Sr. Licensing & Business Development Officer, will be available to m...
According to Silicon Valley Bank report [1], 28% of U.S. startups have a female founder and 14%...
In 2017, the FDA launched its Digital Health Action Plan with legislation specifically targeting dig...
Join us for a panel discussion on the impacts of COVID-19 on the fruit and vegetable markets across ...
During this third series, Bill Pegg, Associate Director for IP at CTL will be joined by two IP Attor...
IGNITE is Cornell Research’s next-generation funding program based on its original gap fund, the Cor...
Kirsten Leute and Margalit Haber at Osage University Partners (OUP) will provide an in-depth look at...
Investment in the U.S. digital health sector has significantly increased from $7.5B in 2019 to $14.1...
Join the Life Science Team at the Center for Technology Licensing (CTL) for an informational and int...